ME
Maine House Bill LD663

Maine 2023-2024 Regular Session

Maine House Bill LD663

Introduced
2/16/23  
Refer
2/16/23  
Refer
2/16/23  

Caption

An Act to Require Health Insurance Coverage for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections and Pediatric Acute-onset Neuropsychiatric Syndrome

Impact

The implementation of LD663 is set to significantly alter the way pediatric healthcare services are financed in the state. By ensuring coverage for treatments deemed necessary for managing these complex disorders, the law aims to alleviate financial burdens on families affected by such conditions. It is anticipated that this legislation will lead to improved access to critical care and potentially better health outcomes for affected children. Coverage mandates will become effective for all insurance policies renewed or initiated on or after January 1, 2024, marking a significant shift in insurance practices concerning pediatric healthcare.

Summary

Legislative Document 663, known as LD663, is designed to mandate health insurance coverage for various pediatric neuropsychiatric disorders, specifically those associated with Streptococcal infections. This legislation requires insurance providers to cover a comprehensive range of treatments for pediatric postinfectious neuroimmune disorders, including medications and interventions pertinent to conditions like pediatric autoimmune neuropsychiatric disorders and pediatric acute-onset neuropsychiatric syndrome. The requirement extends to all health plans offered in the state, ensuring that no coverage exclusions are permitted based solely on specific diagnoses related to autoimmune conditions.

Sentiment

Generally, the sentiment surrounding LD663 appears positive, particularly among advocates for children's health and those directly impacted by autoimmune neuropsychiatric disorders. Supporters of the bill argue that it addresses an urgent need for adequate medical support and reflects a commitment to addressing children's health issues comprehensively. However, some concerns may arise regarding potential increases in healthcare premiums or pushback from insurance companies regarding the broad scope of required coverage, which are typical considerations in the debate over healthcare legislation.

Contention

Notable points of contention related to LD663 involve the potential ramifications for health insurance providers and the financial implications for the state healthcare system. While proponents emphasize the necessity of treatment coverage for affected children, critics might raise concerns about how these mandatory provisions will affect insurance rates and overall healthcare costs. The discussion emphasizes a balancing act between expanding access to essential medical treatments and ensuring the financial sustainability of health insurance coverage in the state.

Latest LD663 Activity

Companion Bills

No companion bills found.

Previously Filed As

ME HB05144

An Act Requiring Health Insurance Coverage For Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections And Pediatric Acute-onset Neuropsychiatric Syndrome.

ME HB2824

Mandating insurance coverage for pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).

ME SB00452

An Act Requiring Health Insurance Coverage For Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections And Pediatric Acute-onset Neuropsychiatric Syndrome.

ME HB2087

In casualty insurance, providing for coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.

ME H8171

Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.

ME S2076

Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.

ME HB1641

State plan for medical assistance services and health insurance; pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.

ME H5625

Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.

ME S0473

Extends coverage for treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome by removing the sunset date of December 31, 2025, and mandating such coverage.

ME HB820

Health Insurance - Pediatric Autoimmune Neuropsychiatric Disorders - Modification of Coverage Requirements

Similar Bills

No similar bills found.